Expression of the CD11c Antigen in B-Cell Chronic Lymphoproliferative Disorders

References

• Springer T.A. Adhesion receptors in the immune system. Nature 1990; 346: 425–434
   PubMed Web of Science ®Google Scholar
• Kishimoto TK, Larson RS, Corbi AL, Dustin ML, Staunton DE, Springer T.A. The leukocyte integrins. Adv Immunol 1989; 46: 149–182
   PubMed Web of Science ®Google Scholar
• Larson RS, Springer TA. Structure and function of leukocyte integrins. Immunol Rev 1990; 114: 181–217
   PubMed Web of Science ®Google Scholar
• Keizer GD, Borst J, Visser W, Schwarting R, De Vries JE, Figdor CG. Membrane glycoprotein p 150,95 of human cytotoxic T cell clones is involved in conjugate formation with target cells. J Immunol 1987; 138: 3130–3136
   PubMed Web of Science ®Google Scholar
• Postigo AA, Corbi AL, Sanchez-Madrid F, de Landazuri MO. Regulated expression and function of CD11c/CD18 integrin on human B lymphocytes. Relation between attachment to fibrinogen and triggering of proliferation through CD11c/CD18. J Exp Med 1991; 17: 1313–1322
   Web of Science ®Google Scholar
• Springer TA, Miller LJ, Anderson DC. P150, 95 the third member of the Mac-1, LFA-1 human leukocyte adhesion glycoprotein family. J Immunol 1986; 136: 240–245
   PubMed Web of Science ®Google Scholar
• Lecoanet-Hencchoz S, Gauchat JF, Aubry JP, Graber P, Life P, Paul-Eugen N, Ferrua B, Corbi AL, Dugas B, Plater-Zyberk C, Bonnefoy JY. CD23 regulates monocyte activation through a novel interaction with the adhesion molecules CD11b-CD18 and CD11c-CD18. Immunity 1995; 3: 119–125
   PubMed Web of Science ®Google Scholar
• Schwarting R, Stein H, Wang CY. The monoclonal antibodies (αLeu-14) and αS-HCL 3 (αLeu-M5) allow the diagnosis of hairy cell leukemia. Blood 1985; 65: 974–983
   PubMed Web of Science ®Google Scholar
• Wormsley SB, Baird SM, Gadol N, Rai KR, Sobol RE. Characteristics of CD11c+ CD5+ chronic B-cell leukemias and the identification of novel pripheral blood B-cell subsets with chronic limphoid leukemia immunophenotypes. Blood 1990; 76: 123–130
   PubMed Web of Science ®Google Scholar
• Hanson CA, Gribbin TE, Schnitzer B, Schlegelmilch JA, Mitchell BS, Stoolman LM. CD11c (Leu-M5) expression characterizes a B-cell chronic lymphoproliferative disorder with features of both chronic lymphocytic leukemia and hairy cell leukemia. Blood 1990; 76: 2360–2367
   PubMed Web of Science ®Google Scholar
• Tassies D, Montserrat E, Villamor N, Rozman C. CD11c positive B-chronic lymphocytic leukemia. Blood 1991; 78: 1893
   PubMed Web of Science ®Google Scholar
• Palutke M, Tabaczka P, Gingrich D. CD11c expression in chronic lymphocytic leukemia. Blood 1992; 80: 2685
   PubMed Web of Science ®Google Scholar
• Molica S., Dattilo A., Mannela A. CD11c expression in B-cell chronic lymphocytic leukemia. Blood 1993; 81: 2466
   PubMed Web of Science ®Google Scholar
• Newman RA, Peterson B, Davey FR, Brabyn C, Collins H, Brunetto VL, Duggan DB, Weiss RB, Royston I, Millard FE, Miller AA, Bloomfield CD. Phenotypic markers and BCL-1 gene rearrangements in B-cell chronic lymphocytic leukemia: A Cancer and Leukemia Group B study. Blood 1993; 82: 1239–1246
   PubMed Web of Science ®Google Scholar
• Eisterer W, Hilbe W, Stauder R, Bechter O, Fend F, Thaler J. An aggressive subtype of B-CLL is characterized by strong CD44 expression and lack of CD11c. Br J Haematol 1996; 93: 661–669
   PubMed Web of Science ®Google Scholar
• Marotta G, Bucalossi A, Galieni P, Bigazzi C, Nuti S, Valensin PE, Bocchia M, Lauria F. CD4+/CD45RA+ “naive” T cells and immunological response to influenza virus vaccine in B-cell chronic lymphocytic leukaemia patients. Acta Haematol 1998; 99: 18–21
   PubMed Web of Science ®Google Scholar
• Lauria F, Raspadori D, Ventura MA, Rondelli D, Testoni N, Tosi P, Michieli M, Damiani D, Malta MR, Tura S. The presence of lymphoid-associated antigens in adult acute myeloid leukemia is devoid of prognostic relevance. Stem Cell 1995; 13: 428
   PubMed Web of Science ®Google Scholar
• Siegel S. Non parametric statistics for the behavioral sciences. Mc Graw-Hill, New York 1956
   Google Scholar
• Defrance TJ, Aubry JP, Rousset F, Vanbervliet B, Bonnefoy JY, Arai N, Takebe Y, Yokota T, Lee F, Arai K, de Vries JE, Banchereau J. Human recombinant interleukin 4 induces Fcε receptors (CD23) on normal human lymphocytes. J Exp Med 1987; 165: 1459–1464
   PubMed Web of Science ®Google Scholar
• Spiegelberg HL. Lymphocytes bearing Fc receptors for IgE. Immunol Rev 1981; 56: 199–218
   PubMed Web of Science ®Google Scholar
• Melewictz FM, Plummer JM, Spiegelberg HL. Comparison of the Fc receptors for IgE on human lymphocytes and monocytes. J Immunol 1982; 129: 563–571
   PubMed Web of Science ®Google Scholar
• Capron M, Jouault T, Prin L, Joseph M, Ameisen JC, Butterworth AE, Papin JP, Kusnierz JP, Capron A. Functional study of a monoclonal antibody to Ige Fc receptor (Fc epsilon RII) of eosinophils, platelets and macrophages. J Exp Med 1986; 164: 72–79
   PubMed Web of Science ®Google Scholar
• Aderka D, Maor Y, Novick D, Engelmann H, Kahn Y, Levo Y, Wallach D, Revel M. Interleukin-6 inhibits the proliferation of B. chronic lymphocytic leukemia cells that is induced by tumor necrosis factor -α or -β. Blood 1993; 81: 2076–2084
   PubMed Web of Science ®Google Scholar